CVSA Earnings & Financial Statements
CVSA
$130.39
+$0.91(+0.70%)
72
Overall
80
Value
63
Tech
73
Quality
Market Cap
$4.38B
Volume
22.80K
52W Range
$86.97 - $156.26
Target Price
$154.20
CVSA earnings and financial statements: CVSA's income statement, balance sheet and cash flow statement, annual and quarterly.
CVSA Annual Financial Statements
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $1.95B | $1.79B | $1.58B | $1.45B | $1.38B |
| Cost of revenue | -$833.66M | -$771.43M | $698.55M | $648.49M | $659.78M |
| Operating income | $383.38M | $341.54M | $217.05M | $168.17M | $76.75M |
| EBITDA | $453.25M | $408.74M | $308.58M | $283.30M | $281.55M |
| Net income | $251.57M | $237.06M | $136.78M | $93.36M | $310.99M |
| EPS (diluted) | $7.04 | $6.18 | $3.39 | $2.05 | $6.56 |
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Total assets | $3.01B | $2.75B | $2.74B | $2.81B | $3.03B |
| Total liabilities | $1.57B | $1.32B | $1.37B | $1.35B | $1.54B |
| Shareholders’ equity | $1.45B | $1.43B | $1.37B | $1.46B | $1.49B |
| Cash and equivalents | $406.32M | $199.60M | $219.31M | $272.19M | $346.97M |
| Long-term debt | $865.60M | $738.84M | $816.42M | $858.52M | $1.02B |
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating cash flow | $470.42M | $337.90M | $295.77M | $191.91M | $10.60M |
| Capital expenditure | -$77.70M | -$42.99M | -$48.89M | -$26.01M | -$31.05M |
| Free cash flow | $392.73M | $287.57M | $246.88M | $165.90M | -$20.45M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CVSA | $130.39 | +0.7% | 22.80K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |